Supplementary Financial Information (Tables)

3 Months Ended

Mar. 31, 2023

Supplemental Financial Information [Abstract]

Schedule of Restricted Cash

Cash, cash equivalents and restricted cash amounts are as follows:

	March 31, 2023		December 31, 2022
Cash and cash equivalents	$	591	$	1,045
Restricted cash
Litigation deposits in Brazil	40		39
Escrow and cash collections related to secured borrowing arrangements(1)	65		54
Other restricted cash	1		1
Total Restricted cash	106		94
Cash, cash equivalents and restricted cash	$	697	$	1,139

_____________

(1)Represents collections on finance receivables pledged for secured borrowings that will be remitted to lenders in the following month.

Schedule of Restricted Cash Balance Sheet Location

Restricted cash is reported in the Condensed Consolidated Balance Sheets as follows:

	March 31, 2023		December 31, 2022
Other current assets	$	65	$	55
Other long-term assets	41		39
Total Restricted cash	$	106	$	94

Schedule Cash Flow Information

Summarized cash flow information is as follows:

	Location in Statement of Cash Flows	Three Months Ended March 31,
Source/(Use)		2023		2022
Provision for receivables	Operating	$	(5)	$	14
Provision for inventory	Operating	5		5
Depreciation of buildings and equipment	Operating	16		18
Depreciation and obsolescence of equipment on operating leases	Operating	27		32
Amortization of internal use software	Operating	10		11
Amortization of acquired intangible assets	Operating	11		11
Amortization of patents(1)	Operating	2		3
Amortization of customer contract costs(2)	Operating	16		19
Cost of additions to land, buildings and equipment	Investing	(6)		(12)
Cost of additions to internal use software	Investing	(2)		(4)
Payments to acquire noncontrolling interests - Xerox Holdings	Investing	(3)		(5)
Common stock dividends - Xerox Holdings	Financing	(41)		(42)
Preferred stock dividends - Xerox Holdings	Financing	(4)		(4)
Payments to noncontrolling interests	Financing	(1)		(1)
Repurchases related to stock-based compensation - Xerox Holdings	Financing	(6)		(10)

_____________

(1)Amortization of patents is reported in Decrease (increase) in other current and long-term assets in the Condensed Consolidated Statements of Cash Flows.

(2)Amortization of customer contract costs is reported in Decrease (increase) in other current and long-term assets in the Condensed Consolidated Statements of Cash Flows. Refer to Note 3 - Revenue - Contract Costs for additional information.